Current Report Filing (8-k)
August 14 2017 - 10:32AM
Edgar (US Regulatory)
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 14, 2017
CHINA JO-JO
DRUGSTORES, INC.
(Exact name of Registrant as specified in charter)
Nevada
|
|
001-34711
|
|
98-0557852
|
(State or other jurisdiction
of Incorporation)
|
|
(Commission File No.)
|
|
(IRS Employer
Identification No.)
|
1st Floor, Yuzheng Plaza, No. 76, Yuhuangshan
Road
Hangzhou, Zhejiang Province, People’s
Republic of China, 310002
(Address of principal executive offices) (Zip
Code)
Registrant's telephone number, including area
code:
+86 (571) 88077078
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant
to Rule 425 under the Securities Act (17CFR230.425)
☐ Soliciting material pursuant to Rule14a-12
under the Exchange Act (17CFR240.14a-12)
☐ Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
☐ Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On August 14, 2017, China
Jo-Jo Drugstores, Inc. (the “Company”) issued a press release announcing certain financial results for the fiscal quarter
ended June 30, 2017. A copy of the press release is attached hereto as Exhibit 99.1.
This information under
this Item 2.02 and the press release attached to this Form 8-K as Exhibit 99.1 shall be deemed to be “furnished” and
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities under that section and shall not be deemed incorporated by reference in any
filing under the Exchange Act or the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following is filed as an exhibit to this
report:
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Earnings Release, dated August 14, 2017.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
CHINA JO-JO DRUGSTORES, INC.
|
|
|
|
Date: August 14, 2017
|
By:
|
/s/ Ming Zhao
|
|
Name:
|
Ming Zhao
|
|
Title:
|
Chief Financial Officer
|
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Aug 2024 to Sep 2024
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Sep 2023 to Sep 2024